MedPath

Investigating the effect of Violet syrup as an subsidiary treatment for insomnia in children with attention deficit hyperactivity disorder

Phase 3
Conditions
Attention deficit hyperactivity disorder.
Attention-deficit hyperactivity disorders
Registration Number
IRCT20230930059556N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Having DSM 5 diagnostic criteria for ADHD
Age 6 to 12 years
Not taking any medication affecting the mental state at least 2 weeks before the research

Exclusion Criteria

Mental retardation
The presence of any psychiatric disorder except OCD
History of allergy to the drugs used in the study
Having a serious medical illness such as heart disease
Uncontrolled seizure disorder
People who have systolic blood pressure above 125 mm Hg or their resting pulse is less than 60 or more than 115 beats per minute.
Weight under 5 13 kg

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath